Top 10 Life Science Angel Investors in Belgium in May 2026
Top 10 Life Science Angel Investors in Belgium in May 2026
| Investor | Life Science Belgium investments |
|---|---|
| Luc Vauterin | 2 |
| Annie Vereecken | 2 |
| Pierre Drion | 2 |
| Piet Van Waes | 1 |
| Jürgen Ingels | 1 |
| Kenneth Buckfire | 1 |
| Virginie Saverys | 1 |
| Evren Ucok | 1 |
| Griet Nuytinck | 1 |
| Annemie Van de Casteele | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Luc Vauterin - Board Member @ ONTOFORCE
Show more...Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Annie Vereecken
Show more...Investment focus
- Medical, Biotechnology, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Piet Van Waes is the Managing Director and Founder of Tilleghem. He previously worked at Green Park Investment Partners as a Partner. Piet Van Waes attended KU Leuven.
Show more...Investment focus
- Hotel, Medical, Tourism
- Seed
- Belgium
Portfolio highlights
- Rookoo — Rookoo is an AI-driven venue management software that talks to your customers, handles the intake, checks availability, fills your CRM or booking software, and hands off to your team for seamless follow-up.
- Tinrate — Tinrate is an easy-to-use connection that allows instructors, experts, and artists to be booked and paid immediately for their services. It serves as a link between your audience and your bank account rather than being a platform full of
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Founding Partner, was the Founder and CFO of Clear2Pay, a leading payments technology company. Under his leadership, he grew the company to one of the world leaders in payment software with more than 1,200 employees in 14 countries and successfully sold the business to FIS for 400 million euro in October 2014. In 2012, Jurgen co-founded NGData, aleading big data company offering customer intelligence management software and services to track customer behavior in real time. He started his career as Investment Manager with Dexia Ventures (previously Quadra Invest), where he focused on investing in early-stage companies while taking a pro-active role in their business strategy, product launches, and financial management.He currently holds Board positions at several technology companies such as Materialise (NASDAQ: MTLS), Itiviti, NGData, Itineris, and Projective and is the founder and Chairman of start-ups.be. Jurgen holds a Masters degree in Political and Social Sciences and an MBA from the University of Antwerp.
Show more...Investment focus
- Software, Analytics, SaaS
- Series B, Funding Round, Seed
- Belgium, Turkey, Finland
Portfolio highlights
- Casper — Casper is a pan European Hybrid Kitchen pioneer and a modern day food hall; 100% virtual and getting everyone what they want. Their vision is to have a foothold in every great city of Europe: a virtual food hall (referring to the wide variety of cuisines available from which you can order) at everyone’s fingertips, from the comfort of their ownhome. Available for in-store purchase, pick-up or within 30 minutes delivery distance. Similar to a dark kitchen, Casper's kitchen operations are takeaway & delivery focused. However, they differ by choosing high street locations where customers are able to walk in and order from a kiosk, click & collect or pick-up from the deli. While they wait for and see how their food is prepared, the branded in-store environment allows them to engage with the brand; completely wiping out the mystery-factor and all misconceptions around ghost kitchens.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
- Willow — With Willow you always know what, how and when to post to build a healthy social media presence. From easy publishing and content inspiration to the best news from all around the web, curated by experts and our algorithm.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more...Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Virginie Saverys is a entrepreneur.
Show more...Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more...Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Griet Nuytinck is founder of Anacura.
Show more...Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Annemie Van de Casteele is a former member of the Belgian Parliament.
Show more...Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!